Monday, October 26, 2026 · Daily editionET --:--:--

Finished

An Exploratory Study of a Wearable Robotic Hand Orthosis

NCT06412237 · Tan Tock Seng Hospital · Updated 7 Oct 2026

What is being tested
RELab tenoexo
For
Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 21 years to 80 years. About 8 people. The full rules are on the registry page.
Where
Singapore
When
Starts or started 1 June 2024, ends 27 Jan 2026. Registered 14 May 2024.
Results
None posted yet.

In the researchers' words

Upper limb deficits usually remain in 75% of the stroke survivors despite completing full rehabilitation. This is due to lack of effectiveness of rehabilitation and the degree of support and resources available. In this study, the investigators plan to study the use of assistive technologies in chronic stroke survivors.
ClinicalTrials.gov, NCT06412237

Sites

  • Tan Tock Seng HospitalSingapore, Singapore, Singapore